Levofloxacin
Product Images NDC 64205-537

5 FDA label images from Readymeds · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 64205-537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Readymeds, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Fig1)

Figure 2: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 750 mg (Levofloxacin Fig1)
A line graph illustrating the mean levofloxacin plasma concentration over time for a 750 mg dose. It compares two administration routes: oral tablet (p.o.) and intravenous infusion (i.v., 90 minutes). The x-axis represents time in hours (0 to 36), and the y-axis shows plasma concentration in mcg/mL (0 to 12). Data points indicate drug concentration decay after peak values.*
FDA Label Image

Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Fig2)

Figure 3: Mean Levofloxacin Plasma Concentration Vs. Time Profile: 500 mg (Levofloxacin Fig2)
A line graph titled 'Mean Levofloxacin Plasma Concentration vs. Time Profile: 500 mg' comparing plasma concentration (mcg/mL) over time (hours) for Levofloxacin 750 mg administered orally (tablet) and intravenously (90 min infusion). The graph shows plasma concentration peak and decline trends for both administration routes over 36 hours.*
FDA Label Image

Chemical Structure (Levofloxacin Str)

Chemical Structure (Levofloxacin Str)
Chemical structure of Levofloxacin shown with detailed molecular bonds and hydration state indicated as half molecule water (1/2 H2O). The image displays the specific arrangement of atoms including fluorine and methyl groups on the quinolone antibiotic backbone.*
FDA Label Image

Package Label-principal Display Panel (500 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (500 mg Blister Carton (10 x 10 Unit-dose))
Label for ReadyMeds Levofloxacin 500 mg showing a quantity of 10 tablets. The label includes NDC 64205-537-10, expiration date 09/2015, and lot number LFSB13026-B.*
FDA Label Image

Package Label-principal Display Panel (500 mg (50 Tablet Bottle))

Package Label-principal Display Panel (500 mg (50 Tablet Bottle))
Label for Levofloxacin 500 mg by ReadyMeds showing a quantity of 7 tablets. Includes the NDC code 64205-537-07, expiration date 09/2015, and lot number LFSB13026-B.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.